OvaRex® MAb is a monoclonal antibody – a biotech drug – designed to help the patient’s immune system recognize and more effectively fight ovarian cancer. OvaRex® MAb is given during the ‘watchful waiting’ period, following successful front-line therapy. It may become recognized as the most significant advance in ovarian cancer treatment since the use of [...]
Ovarian Cancer Research
A hysterectomy is not often a procedure that needs to be performed urgently, except in the case of cancer. Therefore, a woman considering the procedure should take time to investigate all her options, including other possible treatments. There are now new treatments for conditions that previously would have required a hysterectomy. Women advised to have [...]
A large clinical test shows that giving chemotherapy directly into the stomach, as well as into a vein, can improve survival of women with advanced ovarian cancer by about sixteen months. The results of the study, which pop up in this week’s issue of the New England Journal of Medicine, prompted the National Cancer Institute [...]
Mesothelioma is a deadly cancer which is fairly rare although in the last few decades the number of people who have died from it have dramatically increased. Mesothelioma is caused by exposure to asbestos without sufficient protection. When a person is exposed to asbestos, he or she inhales tiny asbestos fibres which are suspended in [...]
This article explains who is at risk for Mesothelioma.
This article explains what exactly puts people at risk for Mesothelioma.
